Advertisement

What is the course of multiple sclerosis (MS)?

The symptoms of multiple sclerosis (MS) can be varied, so it's difficult to diagnose; but early treatment and lifestyle changes can proactively shift the course of the disease. In this video, neurologist Kulreet Chaudhary, MD, explains this concept.

Each case of multiple sclerosis (MS) displays one of several patterns of presentation and subsequent course. Most commonly, MS first manifests itself as a series of attacks followed by complete or partial remissions as symptoms mysteriously lessen only to return later after a period of stability. This is called relapsing-remitting (RR) MS. Primary-progressive (PP) MS is characterized by a gradual clinical decline with no distinct remissions, although there may be temporary plateaus or minor relief from symptoms. Secondary-progressive (SP) MS begins with an RR course followed by a later PP course. Rarely, patients may have a progressive-relapsing (PR) course, in which the disease takes a progressive path punctuated by acute attacks. PP, SP, and PR are sometimes lumped together and called chronic progressive MS.

In addition, 20 percent of the MS population has a benign form of the disease, in which symptoms show little or no progression after the initial attack; these patients remain fully functional. A few patients experience malignant MS, defined as a swift and relentless decline resulting in significant disability or even death shortly after disease onset. However, MS is rarely fatal, and most people with MS have a fairly normal life expectancy.

Studies throughout the world are causing investigators to redefine the natural course of the disease. These studies use a technique called magnetic resonance imaging (MRI) to visualize the evolution of MS lesions in the white matter of the brain. Bright spots on a T2 MRI scan indicate the presence of lesions but do not provide information about when they developed.

Because investigators speculate that the breakdown of the blood-brain barrier is the first step in the development of MS lesions, it is important to distinguish new lesions from old. To do this, physicians give patients injections of gadolinium, a chemical contrast agent that normally does not cross the blood-brain barrier, before performing a scan. On this type of scan, called T1, the appearance of bright areas indicates periods of recent disease activity. The ability to estimate the age of lesions through MRI has allowed investigators to show that in some patients, lesions occur frequently throughout the course of the disease even when no symptoms are present.

This answer is based on source information  from the National Institute of Neurological Disorders and Stroke.

Continue Learning about Multiple Sclerosis (MS)

My Story: Eliz and MS
My Story: Eliz and MS
The right mindset can make a major difference when living with a condition like multiple sclerosis. In this video, Eliz shares her story with MS and h...
Read More
What are the types of multiple sclerosis (MS)?
HealthyWomenHealthyWomen
The general types, or courses, of multiple sclerosis (MS) are as follows: Relapsing-remitting MS ...
More Answers
7 Things a Neurologist Wants You to Know About Multiple Sclerosis
7 Things a Neurologist Wants You to Know About Multiple Sclerosis7 Things a Neurologist Wants You to Know About Multiple Sclerosis7 Things a Neurologist Wants You to Know About Multiple Sclerosis7 Things a Neurologist Wants You to Know About Multiple Sclerosis
Bust the myths—and get the truth—about MS.
Start Slideshow
What New Drug Therapies Treat Multiple Sclerosis Symptoms?
What New Drug Therapies Treat Multiple Sclerosis Symptoms?

Important: This content reflects information from various individuals and organizations and may offer alternative or opposing points of view. It should not be used for medical advice, diagnosis or treatment. As always, you should consult with your healthcare provider about your specific health needs.